| 1 |
Maas AIR , Menon DK , Adelson PD , Andelic N , Bell MJ , Belli A , Bragge P , Brazinova A , Büki A , Chesnut RM , Citerio G , Coburn M , Cooper DJ , Crowder AT , Czeiter E , Czosnyka M , Diaz-Arrastia R , Dreier JP , Duhaime AC , Ercole A , van Essen TA , Feigin VL , Gao G , Giacino J , Gonzalez-Lara LE , Gruen RL , Gupta D , Hartings JA , Hill S , Jiang JY , Ketharanathan N , Kompanje EJO , Lanyon L , Laureys S , Lecky F , Levin H , Lingsma HF , Maegele M , Majdan M , Manley G , Marsteller J , Mascia L , McFadyen C , Mondello S , Newcombe V , Palotie A , Parizel PM , Peul W , Piercy J , Polinder S , Puybasset L , Rasmussen TE , Rossaint R , Smielewski P , Söderberg J , Stanworth SJ , Stein MB , von Steinbüchel N , Stewart W , Steyerberg EW , Stocchetti N , Synnot A , Te Ao B , Tenovuo O , Theadom A , Tibboel D , Videtta W , Wang KKW , Williams WH , Wilson L , Yaffe K . InTBIR Participants and Investigators. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol, 2017, 16: 987- 1048.
doi: 10.1016/S1474-4422(17)30371-X
|
| 2 |
Maas AIR , Menon DK , Manley GT , Abrams M , Åkerlund C , Andelic N , Aries M , Bashford T , Bell MJ , Bodien YG , Brett BL , Büki A , Chesnut RM , Citerio G , Clark D , Clasby B , Cooper DJ , Czeiter E , Czosnyka M , Dams-O'Connor K , De Keyser V , Diaz-Arrastia R , Ercole A , van Essen TA , Falvey É , Ferguson AR , Figaji A , Fitzgerald M , Foreman B , Gantner D , Gao G , Giacino J , Gravesteijn B , Guiza F , Gupta D , Gurnell M , Haagsma JA , Hammond FM , Hawryluk G , Hutchinson P , van der Jagt M , Jain S , Jain S , Jiang JY , Kent H , Kolias A , Kompanje EJO , Lecky F , Lingsma HF , Maegele M , Majdan M , Markowitz A , McCrea M , Meyfroidt G , Mikolić A , Mondello S , Mukherjee P , Nelson D , Nelson LD , Newcombe V , Okonkwo D , Orešič M , Peul W , Pisică D , Polinder S , Ponsford J , Puybasset L , Raj R , Robba C , Røe C , Rosand J , Schueler P , Sharp DJ , Smielewski P , Stein MB , von Steinbüchel N , Stewart W , Steyerberg EW , Stocchetti N , Temkin N , Tenovuo O , Theadom A , Thomas I , Espin AT , Turgeon AF , Unterberg A , Van Praag D , van Veen E , Verheyden J , Vyvere TV , Wang KKW , Wiegers EJA , Williams WH , Wilson L , Wisniewski SR , Younsi A , Yue JK , Yuh EL , Zeiler FA , Zeldovich M , Zemek R . InTBIR Participants and Investigators. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol, 2022, 21: 1004- 1060.
doi: 10.1016/S1474-4422(22)00309-X
|
| 3 |
Mahajan C , Prabhakar H , Bilotta F . Endocrine dysfunction after traumatic brain injury: an ignored clinical syndrome. Neurocrit Care, 2023, 39: 714- 723.
doi: 10.1007/s12028-022-01672-3
|
| 4 |
Rai A , Rajasekar G , Sahoo J , Kumari MM , Anbazhagan S . Anterior pituitary dysfunction after traumatic brain injury: a prospective study. World Neurosurg, 2024, 190: e588- e594.
doi: 10.1016/j.wneu.2024.07.186
|
| 5 |
Hasan S , Uff C . Neuroendocrine dysfunction following traumatic brain injury: current insights and emerging perspectives. Best Pract Res Clin Endocrinol Metab, 2025, 39: 102006.
doi: 10.1016/j.beem.2025.102006
|
| 6 |
Unluhizarci K , Urhan E . Epidemiology and risk factors for hypopituitarism due to traumatic brain injury. Best Pract Res Clin Endocrinol Metab, 2025, 39: 101997.
doi: 10.1016/j.beem.2025.101997
|
| 7 |
Tanriverdi F , Schneider HJ , Aimaretti G , Masel BE , Casanueva FF , Kelestimur F . Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev, 2015, 36: 305- 342.
doi: 10.1210/er.2014-1065
|
| 8 |
Graca GM , Aguiar LR , De Lacerda L . New diagnostic approach to central hypothyroidism after traumatic brain injury in children and adolescents. Eur Thyroid J, 2025, 14: e240184.
|
| 9 |
Mameli C , Orso M , Calcaterra V , Wasniewska MG , Aversa T , Granato S , Bruschini P , Guadagni L , d'Angela D , Spandonaro F , Polistena B , Zuccotti G . Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: a systematic review and meta-analysis. Pharmacol Res, 2023, 193: 106805.
doi: 10.1016/j.phrs.2023.106805
|
| 10 |
Aghili ZS , Khoshnevisan G , Mostoli R , Alibaglouei M , Zarkesh-Esfahani SH . Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives. Mol Biol Rep, 2025, 52: 202.
doi: 10.1007/s11033-025-10304-w
|
| 11 |
Xue CQ , Fu JF . Progress on growth promoting therapies other than growth hormone. Zhejiang Da Xue Xue Bao (Yi Xue Ban), 2022, 51: 515- 520.
|
|
薛初晴, 傅君芬. 生长激素以外的促生长疗法研究进展. 浙江大学学报(医学版), 2022, 51: 515- 520.
|
| 12 |
van Bunderen CC , Olsson DS . Growth hormone deficiency and replacement therapy in adults: impact on survival. Rev Endocr Metab Disord, 2021, 22: 125- 133.
doi: 10.1007/s11154-020-09599-w
|
| 13 |
Bolamperti S , Villa I , di Filippo L . Growth hormone and bone: a basic perspective. Pituitary, 2024, 27: 745- 751.
doi: 10.1007/s11102-024-01464-2
|
| 14 |
Ho KK , O'Sullivan AJ , Burt MG . The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy. J Endocrinol, 2023, 257: e220197.
|
| 15 |
Epardo D , Balderas-Márquez JE , Rodríguez-Arzate CA , Thébault SC , Carranza M , Luna M , Ávila-Mendoza J , Calderón-Vallejo D , Quintanar JL , Arámburo C , Martínez-Moreno CG . Growth hormone neuroprotective effects after an optic nerve crush in the male rat. Invest Ophthalmol Vis Sci, 2024, 65: 17.
|
| 16 |
Lee J , Anderson LJ , Migula D , Yuen KCJ , McPeak L , Garcia JM . Experience of a pituitary clinic for US military veterans with traumatic brain injury. J Endocr Soc, 2021, 5: bvab005.
doi: 10.1210/jendso/bvab005
|
| 17 |
Klose M , Stochholm K , Janukonyté J , Lehman Christensen L , Frystyk J , Andersen M , Laurberg P , Christiansen JS , Feldt-Rasmussen U . Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. J Clin Endocrinol Metab, 2014, 99: 101- 110.
doi: 10.1210/jc.2013-2397
|
| 18 |
Emelifeonwu JA , Flower H , Loan JJ , McGivern K , Andrews PJD . Prevalence of anterior pituitary dysfunction twelve months or more following traumatic brain injury in adults: a systematic review and Meta-analysis. J Neurotrauma, 2020, 37: 217- 226.
doi: 10.1089/neu.2018.6349
|
| 19 |
Kaur P , Sharma S . Recent advances in pathophysiology of traumatic brain injury. Curr Neuropharmacol, 2018, 16: 1224- 1238.
doi: 10.2174/1570159X15666170613083606
|
| 20 |
Pinggera D , Geiger P , Thomé C . Traumatic brain injury. Nervenarzt, 2023, 94: 960- 972.
doi: 10.1007/s00115-023-01546-9
|
| 21 |
Zhang Y , Li Z , Wang H , Pei Z , Zhao S . Molecular biomarkers of diffuse axonal injury: recent advances and future perspectives. Expert Rev Mol Diagn, 2024, 24 (1/2): 39- 47.
|
| 22 |
Bergquist TF , Kew CL , Wisinger AM . Traumatic brain injury. Neurol Clin, 2024, 42: 863- 874.
doi: 10.1016/j.ncl.2024.05.011
|
| 23 |
Alberts A , Lucke-Wold B . Updates on improving imaging modalities for traumatic brain injury. J Integr Neurosci, 2023, 22: 142.
doi: 10.31083/j.jin2206142
|
| 24 |
Russo L , Kazmi A , Ahmed N . Current management and future challenges in the management of severe traumatic brain injury. Medicina (Kaunas), 2025, 61: 738.
doi: 10.3390/medicina61040738
|
| 25 |
Nadeem M , Shahzad UB , Ahmed M , Khan MAF . Biomarkers in severe traumatic brain injury: enhancing prognostic accuracy and therapeutic strategies. Neurosurg Rev, 2024, 47: 608.
doi: 10.1007/s10143-024-02797-z
|
| 26 |
McDonald BZ , Tarudji AW , Zhang H , Ryu S , Eskridge KM , Kievit FM . Traumatic brain injury heterogeneity affects cell death and autophagy. Exp Brain Res, 2024, 242: 1645- 1658.
doi: 10.1007/s00221-024-06856-1
|
| 27 |
Cáceres E , Olivella JC , Di Napoli M , Raihane AS , Divani AA . Immune response in traumatic brain injury. Curr Neurol Neurosci Rep, 2024, 24: 593- 609.
doi: 10.1007/s11910-024-01382-7
|
| 28 |
Jassam YN , Izzy S , Whalen M , McGavern DB , El Khoury J . Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron, 2017, 95: 1246- 1265.
doi: 10.1016/j.neuron.2017.07.010
|
| 29 |
Orr TJ , Lesha E , Kramer AH , Cecia A , Dugan JE , Schwartz B , Einhaus SL . Traumatic brain injury: a comprehensive review of biomechanics and molecular pathophysiology. World Neurosurg, 2024, 185: 74- 88.
doi: 10.1016/j.wneu.2024.01.084
|
| 30 |
Wang Y , Tian J , Liu D , Li T , Mao Y , Zhu C . Microglia in radiation-induced brain injury: cellular and molecular mechanisms and therapeutic potential. CNS Neurosci Ther, 2024, 30: e14794.
doi: 10.1111/cns.14794
|
| 31 |
Walker KR , Tesco G . Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front Aging Neurosci, 2013, 5: 29.
|
| 32 |
Studzinski AL , Barros DM , Marins LF . Growth hormone (GH) increases cognition and expression of ionotropic glutamate receptors (AMPA and NMDA) in transgenic zebrafish (Danio rerio). Behav Brain Res, 2015, 294: 36- 42.
doi: 10.1016/j.bbr.2015.07.054
|
| 33 |
Moscona-Nissan A , Sidauy-Adissi J , Hermoso-Mier KX , Glick-Betech SS , Chávez-Vera LJ , Martinez-Mendoza F , Delgado-Casillas OM , Taniguchi-Ponciano K , Marrero-Rodríguez D , Mercado M . Diagnosis and treatment of pituitary apoplexy, a true endocrine emergency. Arch Med Res, 2024, 55: 103001.
doi: 10.1016/j.arcmed.2024.103001
|
| 34 |
Gasco V , Cambria V , Bioletto F , Ghigo E , Grottoli S . Traumatic brain injury as frequent cause of hypopituitarism and growth hormone deficiency: epidemiology, diagnosis, and treatment. Front Endocrinol (Lausanne), 2021, 12: 634415.
doi: 10.3389/fendo.2021.634415
|
| 35 |
Visser K , Koggel M , Blaauw J , van der Horn HJ , Jacobs B , van der Naalt J . Blood-based biomarkers of inflammation in mild traumatic brain injury: a systematic review. Neurosci Biobehav Rev, 2022, 132: 154- 168.
doi: 10.1016/j.neubiorev.2021.11.036
|
| 36 |
Mingoti MED , Bertollo AG , de Oliveira T , Ignácio ZM . Stress and kynurenine-inflammation pathway in major depressive disorder. Adv Exp Med Biol, 2023, 1411: 163- 190.
|
| 37 |
Menotti S , Giampietro A , Raia S , Veleno M , Angelini F , Tartaglione T , Gaudino S , Doglietto F , De Marinis L , Pontecorvi A , Bianchi A , Chiloiro S . Unveiling the etiopathogenic spectrum of hypophysitis: a narrative review. J Pers Med, 2023, 13: 1210.
doi: 10.3390/jpm13081210
|
| 38 |
Hegdekar N , Sarkar C , Bustos S , Ritzel RM , Hanscom M , Ravishankar P , Philkana D , Wu J , Loane DJ , Lipinski MM . Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes. Autophagy, 2023, 19: 2026- 2044.
doi: 10.1080/15548627.2023.2167689
|
| 39 |
Tanriverdi F , De Bellis A , Bizzarro A , Sinisi AA , Bellastella G , Pane E , Bellastella A , Unluhizarci K , Selcuklu A , Casanueva FF , Kelestimur F . Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity. Eur J Endocrinol, 2008, 159: 7- 13.
doi: 10.1530/EJE-08-0050
|
| 40 |
Lippa SM , Lange RT , Dalgard CL , Soltis AR , Guedes VA , Brickell TA , French LM , Gill J . APOE is associated with serum tau following uncomplicated mild traumatic brain injury. Front Neurol, 2022, 13: 816625.
doi: 10.3389/fneur.2022.816625
|
| 41 |
Shi Y , Andhey PS , Ising C , Wang K , Snipes LL , Boyer K , Lawson S , Yamada K , Qin W , Manis M , Serrano JR , Benitez BA , Schmidt RE , Artyomov M , Ulrich JD , Holtzman DM . Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron, 2021, 109: 2413- 2426.
doi: 10.1016/j.neuron.2021.05.034
|
| 42 |
Windham IA , Cohen S . The cell biology of APOE in the brain. Trends Cell Biol, 2024, 34: 338- 348.
doi: 10.1016/j.tcb.2023.09.004
|
| 43 |
Laskowitz DT , Van Wyck DW . ApoE mimetic peptides as therapy for traumatic brain injury. Neurotherapeutics, 2023, 20: 1496- 1507.
doi: 10.1007/s13311-023-01413-0
|
| 44 |
Anderson C , Carmichael J , Hicks AJ , Burke R , Ponsford J . Interaction between APOE ε4 and age is associated with emotional distress one year after moderate-severe traumatic brain injury. J Neurotrauma, 2023, 40 (3/4): 326- 336.
|
| 45 |
Nkiliza A , Huguenard CJC , Aldrich GJ , Ferguson S , Cseresznye A , Darcey T , Evans JE , Dretsch M , Mullan M , Crawford F , Abdullah L . Levels of arachidonic acid-derived oxylipins and anandamide are elevated among military APOE ε4 carriers with a history of mild traumatic brain injury and post-traumatic stress disorder symptoms. Neurotrauma Rep, 2023, 4: 643- 654.
doi: 10.1089/neur.2023.0045
|
| 46 |
Amoo M , O'Halloran PJ , Henry J , Ben Husien M , Brennan P , Campbell M , Caird J , Curley GF . Permeability of the blood-brain barrier after traumatic brain injury: radiological considerations. J Neurotrauma, 2022, 39 (1/2): 20- 34.
|
| 47 |
Qin D , Wang J , Le A , Wang TJ , Chen X , Wang J . Traumatic brain injury: ultrastructural features in neuronal ferroptosis, glial cell activation and polarization, and blood-brain barrier breakdown. Cells, 2021, 10: 1009.
doi: 10.3390/cells10051009
|
| 48 |
George KK , Heithoff BP , Shandra O , Robel S . Mild traumatic brain injury/concussion initiates an atypical astrocyte response caused by blood-brain barrier dysfunction. J Neurotrauma, 2022, 39 (1/2): 211- 226.
|
| 49 |
Luan Y , Jiang L , Luan Y , Xie Y , Yang Y , Ren KD . Mitophagy and traumatic brain injury: regulatory mechanisms and therapeutic potentials. Oxid Med Cell Longev, 2023, ID1649842.
|
| 50 |
Tabassum S , Wu S , Lee CH , Yang BSK , Gusdon AM , Choi HA , Ren XS . Mitochondrial-targeted therapies in traumatic brain injury: from bench to bedside. Neurotherapeutics, 2025, 22: e00515.
doi: 10.1016/j.neurot.2024.e00515
|
| 51 |
Oikonomakos I , Siow R , Bornstein SR , Steenblock C . The role of growth hormone-releasing hormone and the hypothalamic-pituitary-somatotropic axis in aging: potential therapeutic applications and risks. Horm Metab Res, 2025,
|
| 52 |
Dieguez C , López M , Casanueva F . Hypothalamic GHRH. Rev Endocr Metab Disord, 2025, 26: 297- 303.
doi: 10.1007/s11154-025-09951-y
|
| 53 |
Noh JY , Herrera M , Patil BS , Tan XD , Wright GA , Sun Y . The expression and function of growth hormone secretagogue receptor in immune cells: a current perspective. Exp Biol Med (Maywood), 2022, 247: 2184- 2191.
doi: 10.1177/15353702221121635
|
| 54 |
Gujral J , Kidd BA , Becker C , Golden E , Lee HC , Kim-Schulze S , Yau M , Dudley J , Rapaport R . Acute effects of growth hormone on the cellular immunologic landscape in pediatric patients. Cureus, 2024, 16: e57383.
|
| 55 |
Stefanakis K , Upadhyay J , Ramirez-Cisneros A , Patel N , Sahai A , Mantzoros CS . Leptin physiology and pathophysiology in energy homeostasis, immune function, neuroendocrine regulation and bone health. Metabolism, 2024, 161: 156056.
doi: 10.1016/j.metabol.2024.156056
|
| 56 |
Shrief AI , Hamed WHE , Mazroa SA , Moustafa AM . Growth hormone enhances the CD34+ stem cells repopulation of the male albino rat thymus gland in cyclophosphamide induced injury: immunohistochemical and electron microscopic study. Ultrastruct Pathol, 2023, 47: 1- 18.
doi: 10.1080/01913123.2022.2156639
|
| 57 |
Reis MDDS , Veneziani LP , Porto FL , Lins MP , Mendes-da-Cruz DA , Savino W . Intrathymic somatotropic circuitry: consequences upon thymus involution. Front Immunol, 2023, 14: 1108630.
doi: 10.3389/fimmu.2023.1108630
|
| 58 |
Caballero-Villarraso J , Aguado R , Cañete MD , Roldán L , Cañete R , Santamaría M . Hormone replacement therapy in children with growth hormone deficiency: impact on immune profile. Arch Physiol Biochem, 2021, 127: 245- 249.
doi: 10.1080/13813455.2019.1628070
|
| 59 |
Zhang C , Tian R , Dreifus EM , Hashemi Shahraki A , Holt G , Cai R , Griswold A , Bejarano P , Jackson R , V Schally A , Mirsaeidi M . Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma. Clin Transl Immunology, 2021, 10: e1310.
doi: 10.1002/cti2.1310
|
| 60 |
Du L , Ho BM , Zhou L , Yip YWY , He JN , Wei Y , Tham CC , Chan SO , Schally AV , Pang CP , Li J , Chu WK . Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation. Nat Commun, 2023, 14: 3298.
doi: 10.1038/s41467-023-39023-1
|
| 61 |
Welniak LA , Sun R , Murphy WJ . The role of growth hormone in T-cell development and reconstitution. J Leukoc Biol, 2002, 71: 381- 387.
doi: 10.1189/jlb.71.3.381
|
| 62 |
Pech-Pool S , Berumen LC , Martínez-Moreno CG , García-Alcocer G , Carranza M , Luna M , Arámburo C . Thyrotropin-releasing hormone (TRH) and somatostatin (SST), but not growth hormone-releasing hormone (GHRH) nor ghrelin (GHRL), regulate expression and release of immune growth hormone (GH) from chicken bursal B-lymphocyte cultures. Int J Mol Sci, 2020, 21: 1436.
doi: 10.3390/ijms21041436
|
| 63 |
Hattori N . Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res, 2009, 19: 187- 197.
doi: 10.1016/j.ghir.2008.12.001
|
| 64 |
Sodhi A , Tripathi A . Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-kappaB. Cytokine, 2008, 41: 162- 173.
doi: 10.1016/j.cyto.2007.11.007
|
| 65 |
Liu QL , Wang YS , Wang JX . Effect of growth hormone on the immune function of dendritic cells. Chin Med J (Engl), 2010, 123: 1078- 1083.
|
| 66 |
Li GY , Wu QZ , Song TJ , Zhen XC , Yu X . Dynamic regulation of excitatory and inhibitory synaptic transmission by growth hormone in the developing mouse brain. Acta Pharmacol Sin, 2023, 44: 1109- 1121.
doi: 10.1038/s41401-022-01027-w
|
| 67 |
Kirazli O , Ozkan M , Verimli U , Gulhan R , Arman A , Sehirli US . The effect of growth hormone on motor findings and dendrite morphology in an experimental Parkinson's disease model. Anat Sci Int, 2025, 100: 79- 87.
doi: 10.1007/s12565-024-00790-6
|
| 68 |
Lopez J , Quan A , Budihardjo J , Xiang S , Wang H , Kiron Koshy , Cashman C , Lee WPA , Hoke A , Tuffaha S , Brandacher G . Growth hormone improves nerve regeneration, muscle re-innervation, and functional outcomes after chronic denervation injury. Sci Rep, 2019, 9: 3117.
doi: 10.1038/s41598-019-39738-6
|
| 69 |
Kraemer RR , Kraemer BR . The effects of peripheral hormone responses to exercise on adult hippocampal neurogenesis. Front Endocrinol (Lausanne), 2023, 14: 1202349.
doi: 10.3389/fendo.2023.1202349
|
| 70 |
Tian J , Guo L , Wang T , Jia K , Swerdlow RH , Zigman JM , Du H . Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline. JCI Insight, 2023, 8: e166175.
doi: 10.1172/jci.insight.166175
|
| 71 |
Li N , Li N , Yang L , Gu H , Ji J , Zhou H , Zhu Q , Yu M , Sun Y , Zhou Y . GHSR1a deficiency suppresses inhibitory drive on dCA1 pyramidal neurons and contributes to memory reinforcement. Cereb Cortex, 2023, 33: 2612- 2625.
doi: 10.1093/cercor/bhac230
|
| 72 |
Sanchez-Bezanilla S , Åberg ND , Crock P , Walker FR , Nilsson M , Isgaard J , Ong LK . Growth hormone treatment promotes remote hippocampal plasticity after experimental cortical stroke. Int J Mol Sci, 2020, 21: 4563.
doi: 10.3390/ijms21124563
|
| 73 |
Zhang Z , Wu X , Kong Y , Zou P , Wang Y , Zhang H , Cui G , Zhu W , Chen H . Dynamic changes and effects of H2S, IGF-1, and GH in the traumatic brain injury. Biochem Genet, 2024, 62: 3821- 3840.
doi: 10.1007/s10528-023-10557-9
|
| 74 |
Sanchez-Bezanilla S , Åberg ND , Crock P , Walker FR , Nilsson M , Isgaard J , Ong LK . Growth hormone promotes motor function after experimental stroke and enhances recovery-promoting mechanisms within the peri-infarct area. Int J Mol Sci, 2020, 21: 606.
doi: 10.3390/ijms21020606
|
| 75 |
Serhan A , Aerts JL , Boddeke EWGM , Kooijman R . Neuroprotection by insulin-like growth factor-1 in rats with ischemic stroke is associated with microglial changes and a reduction in neuroinflammation. Neuroscience, 2020, 426: 101- 114.
doi: 10.1016/j.neuroscience.2019.11.035
|
| 76 |
Yang W , Li G , Cao K , Ma P , Guo Y , Tong W , Wan J . Exogenous insulin-like growth factor 1 attenuates acute ischemic stroke-induced spatial memory impairment via modulating inflammatory response and tau phosphorylation. Neuropeptides, 2020, 83: 102082.
doi: 10.1016/j.npep.2020.102082
|
| 77 |
Li Y , Yang W , Li J , Zhang Y , Zhang L , Chen S , He L , Zhang Y . Relationship between serum insulin-like growth factor 1 levels and ischaemic stroke: a systematic review and meta-analysis. BMJ Open, 2022, 12: e045776.
doi: 10.1136/bmjopen-2020-045776
|
| 78 |
Yuen KCJ , Biller BMK , Radovick S , Carmichael JD , Jasim S , Pantalone KM , Hoffman AR . American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract, 2019, 25: 1191- 1232.
doi: 10.4158/GL-2019-0405
|
| 79 |
Tritos NA , Biller BMK . Current concepts of the diagnosis of adult growth hormone deficiency. Rev Endocr Metab Disord, 2021, 22: 109- 116.
doi: 10.1007/s11154-020-09594-1
|
| 80 |
Rey RA , Bergadá I , Ballerini MG , Braslavsky D , Chiesa A , Freire A , Grinspon RP , Keselman A , Arcari A . Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients. Rev Endocr Metab Disord, 2024, 25: 555- 573.
doi: 10.1007/s11154-023-09868-4
|
| 81 |
Mercier LJ , Kruger N , Le QB , Fung TS , Kline GA , Debert CT . Growth hormone deficiency testing and treatment following mild traumatic brain injury. Sci Rep, 2021, 11: 8534.
doi: 10.1038/s41598-021-87385-7
|
| 82 |
Wexler TL . Neuroendocrine disruptions following head injury. Curr Neurol Neurosci Rep, 2023, 23: 213- 224.
doi: 10.1007/s11910-023-01263-5
|
| 83 |
Wexler TL , Reifschneider K , Backeljauw P , Cárdenas JF , Hoffman AR , Miller BS , Yuen KCJ . Growth hormone deficiency following traumatic brain injury in pediatric and adolescent patients: presentation, treatment, and challenges of transitioning from pediatric to adult services. J Neurotrauma, 2023, 40 (13/14): 1274- 1285.
|
| 84 |
Eggertsdóttir Claessen LÓ , Kristjánsdóttir H , Jónsdóttir MK , Lund SH , Unnsteinsdóttir Kristensen I , Sigurjónsdóttir HÁ . Pituitary dysfunction following mild traumatic brain injury in female athletes. Endocr Connect, 2024, 13: e230363.
|
| 85 |
Daskas N , Sharples P , Likeman M , Lightman S , Crowne E . Cortisol dynamics, quality of life, and fatigue following traumatic brain injury in childhood. Horm Res Paediatr, 2025, 98: 31- 39.
doi: 10.1038/s41390-025-04016-x
|
| 86 |
Leal-Cerro A , Flores JM , Rincon M , Murillo F , Pujol M , Garcia-Pesquera F , Dieguez C , Casanueva FF . Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin Endocrinol (Oxf), 2005, 62: 525- 532.
doi: 10.1111/j.1365-2265.2005.02250.x
|
| 87 |
Molitch ME , Clemmons DR , Malozowski S , Merriam GR , Shalet SM , Vance ML , Endocrine Society's Clinical Guidelines Subcommittee , Stephens PA . Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2006, 91: 1621- 1634.
doi: 10.1210/jc.2005-2227
|
| 88 |
Liao X , Huang H , Qiu B , Chen J , Zhang A , Liang H , Huang C , Mei F , Mao J , Liu F , Jin M , Peng X , Ma H , Ding W , Qi S , Bao Y . Effects of recombinant human growth hormone in severe neurosurgical patients: a single center, retrospective study. PLoS One, 2025, 20: e0317219.
doi: 10.1371/journal.pone.0317219
|
| 89 |
Bensalah M , Donaldson M , Labassen M , Cherfi L , Nebbal M , Haffaf EM , Abdennebi B , Guenane K , Kemali Z , Ould Kablia S . Prevalence of hypopituitarism and quality of life in survivors of post-traumatic brain injury. Endocrinol Diabetes Metab, 2020, 3: e00146.
doi: 10.1002/edm2.146
|
| 90 |
McLoughlin RJ , Swanson RL 2nd . Hypopituitarism after mild traumatic brain injury: a case report. Cureus, 2023, 15: e41282.
|
| 91 |
Heredia M , Sánchez-Robledo V , Gómez I , Criado JM , Fuente A , Devesa J , Devesa P , Riolobos AS . Cell proliferation in the piriform cortex of rats with motor cortex ablation treated with growth hormone and rehabilitation. Int J Mol Sci, 2021, 22: 5440.
doi: 10.3390/ijms22115440
|
| 92 |
Ciarlone SL , Statz JK , Goodrich JA , Norris JN , Goforth CW , Ahlers ST , Tschiffely AE . Neuroendocrine function and associated mental health outcomes following mild traumatic brain injury in OEF-deployed service members. J Neurosci Res, 2020, 98: 1174- 1187.
doi: 10.1002/jnr.24604
|
| 93 |
Fernández-Garza LE , Guillen-Silva F , Sotelo-Ibarra MA , Domínguez-Mendoza AE , Barrera-Barrera SA , Barrera-Saldaña HA . Growth hormone and aging: a clinical review. Front Aging, 2025, 6: 1549453.
doi: 10.3389/fragi.2025.1549453
|
| 94 |
Haria JM , Singh NK , Kumar J , Jain SK , Pamidimarri D . Metabolic and endocrine dysfunctions in traumatic brain injury: implications for cognitive recovery and therapeutic strategies. Behav Brain Res, 2025, 493: 115697.
doi: 10.1016/j.bbr.2025.115697
|
| 95 |
Falleti MG , Maruff P , Burman P , Harris A . The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology, 2006, 31: 681- 691.
doi: 10.1016/j.psyneuen.2006.01.005
|
| 96 |
Pavlovic D , Pekic S , Stojanovic M , Zivkovic V , Djurovic B , Jovanovic V , Miljic N , Medic-Stojanoska M , Doknic M , Miljic D , Djurovic M , Casanueva F , Popovic V . Chronic cognitive sequelae after traumatic brain injury are not related to growth hormone deficiency in adults. Eur J Neurol, 2010, 17: 696- 702.
doi: 10.1111/j.1468-1331.2009.02910.x
|
| 97 |
Herodes M , Le N , Anderson LJ , Migula D , Miranda G , Paulsen L , Garcia JM . Metabolic and quality of life effects of growth hormone replacement in patients with TBI and AGHD: a pilot study. Growth Horm IGF Res, 2023, 71: 101544.
doi: 10.1016/j.ghir.2023.101544
|
| 98 |
Herodes M , Legaspi A , Garcia JM . Mild traumatic brain injury as a cause of adult growth hormone deficiency: diagnosis and treatment. Best Pract Res Clin Endocrinol Metab, 2023, 37: 101818.
doi: 10.1016/j.beem.2023.101818
|
| 99 |
Marina D , Feldt-Rasmussen U , Klose M . Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury. Eur J Endocrinol, 2024, 190: 382- 390.
doi: 10.1093/ejendo/lvae047
|
| 100 |
Gardner CJ , Mattsson AF , Daousi C , Korbonits M , Koltowska-Haggstrom M , Cuthbertson DJ . GH deficiency after traumatic brain injury, improvement in quality of life with GH therapy: analysis of the KIMS database. Eur J Endocrinol, 2015, 172: 371- 381.
doi: 10.1530/EJE-14-0654
|
| 101 |
Szarka N , Szellar D , Kiss S , Farkas N , Szakacs Z , Czigler A , Ungvari Z , Hegyi P , Buki A , Toth P . Effect of growth hormone on neuropsychological outcomes and quality of life of patients with traumatic brain injury: a systematic review. J Neurotrauma, 2021, 38: 1467- 1483.
doi: 10.1089/neu.2020.7265=|J Antimicrob Chemother||77|4|934|2022|||
|
| 102 |
Stochholm K , Kiess W . Long-term safety of growth hormone: a combined registry analysis. Clin Endocrinol (Oxf), 2018, 88: 515- 528.
doi: 10.1111/cen.13502
|
| 103 |
Mossberg KA , Durham WJ , Zgaljardic DJ , Gilkison CR , Danesi CP , Sheffield-Moore M , Masel BE , Urban RJ . Functional changes after recombinant human growth hormone replacement in patients with chronic traumatic brain injury and abnormal growth hormone secretion. J Neurotrauma, 2017, 34: 845- 852.
doi: 10.1089/neu.2016.4552
|